Rules of co-occurring mutations characterize the antigenic evolution of human influenza A/H3N2, A/H1N1 and B viruses

Abstract

BackgroundThe human influenza viruses undergo rapid evolution (especially in hemagglutinin (HA), a glycoprotein on the surface of the virus), which enables the virus population to constantly evade the human immune system. Therefore, the vaccine has to be updated every year to stay effective. There is a need to characterize the evolution of influenza viruses for better selection of vaccine candidates and the prediction of pandemic strains. Studies have shown that the influenza hemagglutinin evolution is driven by the simultaneous mutations at antigenic sites. Here, we analyze simultaneous or co-occurring mutations in the HA protein of human influenza A/H3N2, A/H1N1 and B viruses to predict potential mutations, characterizing the antigenic evolution.MethodsWe obtain the rules of mutation co-occurrence using association rule mining after extracting HA1 sequences and detect co-mutation sites under strong selective pressure. Then we predict the potential drifts with specific mutations of the viruses based on the rules and compare the results with the “observed” mutations in different years.ResultsThe sites under frequent mutations are in antigenic regions (epitopes) or receptor binding sites.ConclusionsOur study demonstrates the co-occurring site mutations obtained by rule mining can capture the evolution of influenza viruses, and confirms that cooperative interactions among sites of HA1 protein drive the influenza antigenic evolution.Electronic supplementary materialThe online version of this article (doi:10.1186/s12920-016-0230-5) contains supplementary material, which is available to authorized users.

A Phase 1 Randomized Placebo-Controlled Study to Assess the Safety, Immunogenicity and Genetic Stability of a New Potential Pandemic H7N9 Live Attenuated Influenza Vaccine in Healthy Adults

“…In contrast to other respiratory viruses, type A influenza viruses display high genetic flexibility. They circulate in different species of mammals and birds [37], undergo frequent genetic reassortment and have a high mutation rate that leads to variability in the surface proteins, HA and NA [38]. This natural genetic variability of influenza A virus means that recommendations on the composition of seasonal influenza virus vaccines need to be updated twice a year, for the northern and the southern hemisphere [39].…”

Will We Ever be Able to Defeat Human Influenza?

“…Unlike other respiratory viruses, influenza viruses, especially type A display vast natural genetic variability. They circulate in different animal species of birds and mammals [5], undergo a high mutation rate and frequent genetic reassortment that lead to variability in surface proteins, HA and NA [6]. High genetic flexibility of influenza A virus forces World Health Organiztion (WHO) experts to update recommendations on the composition of influenza virus vaccines twice a year [7].…”

Molecular evolution of hemagglutinin gene of Influenza A virus

“…HA undergoes rapid evolution to evade host immune system. Most mutations in HA occur in the RBS and antigenic site of HA1 domain (49). HA evolves three times faster than the non-structural genes (50).…”